These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 28167550
1. Acquisition of Rifampin Resistance in Pulmonary Tuberculosis. Kayigire XA, Friedrich SO, van der Merwe L, Diacon AH. Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167550 [Abstract] [Full Text] [Related]
2. RpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis strains isolated in the Aegean region of Turkey. Avkan Oguz V, Eroglu C, Guneri S, Yapar N, Oztop A, Sanic A, Yuce A. J Chemother; 2004 Oct; 16(5):442-5. PubMed ID: 15565909 [Abstract] [Full Text] [Related]
3. Drug-resistant tuberculosis among previously treated patients in Yangon, Myanmar. Tun T, Nyunt WW, Latt KZ, Samaranayaka A, Crump JA, Thinn KK, Cook GM, Aung HL. Int J Mycobacteriol; 2016 Sep; 5(3):366-367. PubMed ID: 27847028 [No Abstract] [Full Text] [Related]
4. [The Spectrum of Mutations in Genes Associated with Resistance to Rifampicin, Isoniazid, and Fluoroquinolones in the Clinical Strains of M. tuberculosis Reflects the Transmissibility of Mutant Clones]. Ergeshov A, Andreevskaya SN, Larionova EE, Smirnova TG, Chernousova LN. Mol Biol (Mosk); 2017 Sep; 51(4):595-602. PubMed ID: 28900077 [Abstract] [Full Text] [Related]
5. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens. Kostera J, Leckie G, Tang N, Lampinen J, Szostak M, Abravaya K, Wang H. Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383 [Abstract] [Full Text] [Related]
7. Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. Bártfai Z, Somoskövi A, Ködmön C, Szabó N, Puskás E, Kosztolányi L, Faragó E, Mester J, Parsons LM, Salfinger M. J Clin Microbiol; 2001 Oct; 39(10):3736-9. PubMed ID: 11574605 [Abstract] [Full Text] [Related]
8. Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Düzce, Turkey. Ozturk CE, Sanic A, Kaya D, Ceyhan I. Jpn J Infect Dis; 2005 Oct; 58(5):309-12. PubMed ID: 16249627 [Abstract] [Full Text] [Related]
9. Evaluation of the rpoB macroarray assay to detect rifampin resistance in Mycobacterium tuberculosis in Beijing, China. Mokrousov I, Jiao WW, Sun GZ, Liu JW, Li M, Narvskaya O, Shen AD. Eur J Clin Microbiol Infect Dis; 2006 Nov; 25(11):703-10. PubMed ID: 17061099 [Abstract] [Full Text] [Related]
10. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates. Soudani A, Hadjfredj S, Zribi M, Masmoudi A, Messaoud T, Tiouri H, Fendri C. J Clin Microbiol; 2007 Sep; 45(9):3095-7. PubMed ID: 17652484 [Abstract] [Full Text] [Related]
11. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey. Aslan G, Tezcan S, Serin MS, Emekdas G. Jpn J Infect Dis; 2008 Jul; 61(4):255-60. PubMed ID: 18653964 [Abstract] [Full Text] [Related]
12. The evolution of drug resistance in Mycobacterium tuberculosis: from a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population. Bifani P, Mathema B, Kurepina N, Shashkina E, Bertout J, Blanchis AS, Moghazeh S, Driscoll J, Gicquel B, Frothingham R, Kreiswirth BN. J Infect Dis; 2008 Jul 01; 198(1):90-4. PubMed ID: 18498237 [Abstract] [Full Text] [Related]
13. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Jiao WW, Mokrousov I, Sun GZ, Li M, Liu JW, Narvskaya O, Shen AD. Chin Med J (Engl); 2007 May 05; 120(9):814-9. PubMed ID: 17531124 [Abstract] [Full Text] [Related]
14. [ANALYSIS OF MUTATION IN CODON 531 rpoB GENE, ASSOCIATED WITH RIFAMPICIN RESISTANCE AMONG SAMPLES OF MYCOBACTERIUM TUBERCULOSIS THAT WAS ISOLATED FROM THE PATIENTS]. Poteĭko PI, Liashenko AA, Lebed' LV, Dymova MA, Kryt'ko VS, Filipenko ML, Kashuba DA. Lik Sprava; 2014 May 05; (7-8):65-9. PubMed ID: 26118085 [Abstract] [Full Text] [Related]
15. Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3. Li W, Obregón-Henao A, Wallach JB, North EJ, Lee RE, Gonzalez-Juarrero M, Schnappinger D, Jackson M. Antimicrob Agents Chemother; 2016 Sep 05; 60(9):5198-207. PubMed ID: 27297488 [Abstract] [Full Text] [Related]
16. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJ. Science; 2006 Jun 30; 312(5782):1944-6. PubMed ID: 16809538 [Abstract] [Full Text] [Related]
18. Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia. Tadesse M, Aragaw D, Dimah B, Efa F, Abdella K, Kebede W, Abdissa K, Abebe G. Int J Mycobacteriol; 2016 Jun 30; 5(2):185-91. PubMed ID: 27242230 [Abstract] [Full Text] [Related]
19. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis. Abbadi SH, Sameaa GA, Morlock G, Cooksey RC. Int J Infect Dis; 2009 Nov 30; 13(6):673-8. PubMed ID: 19138546 [Abstract] [Full Text] [Related]
20. [Reasons for drug-resistant tuberculosis emergence]. Tu DH. Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun 30; 30(6):403-5. PubMed ID: 17673006 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]